Pluristem Therapeutics Inc (PSTI)

[Spideyboy]

I think saying that you can't find a reasonable explanation how this would be positive in the least goes a little far.

As mentioned, the fact that the Ireali sites are coming online given prior dosing and effect in the open label study to date would mean that at the very least nothing bad has happened and logically would assume that benefits have been seen otherwise why bring yourself in?

Also Midas, while this is for this specific Phase I indication, the greater and more imminent value I understand from this trial is that this will be able to provide the Human safety data on R18 that everyone keeps worrying about and would be submitted with the ARS macaque information.

So again the fact that these Isreali sites are coming online, should be positive.